Recent Press Releases

Novo Nordisk to Launch Novoeight® in the United States for People With Hemophilia A

PLAINSBORO, N.J. -- Novo Nordisk today announced the company will launch Novoeight®(Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A. Novoeight®...

Shire and Cincinnati Children's Establish Rare Disease Research Collaboration

LEXINGTON, Massachusetts and CINCINNATI, March 26, 2015 -- Shire plc (LSE: SHP, NASDAQ: SHPG) and Cincinnati Children's Hospital Medical Center today announced a three-year, broad research...

European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS

CAMBRIDGE, Mass. & NORTH CHICAGO, Ill.--Today Biogen (NASDAQ: BIIB) and AbbVie (NYSE: ABBV) announced that the European Medicines Agency (EMA) has validated the companies' Marketing...

Novo Nordisk has decided to resubmit the New Drug Applications of Tresiba® and Ryzodeg® in the US

Bagsværd, Denmark, 26 March 2015 – Novo Nordisk today announced that the company has decided to submit the prespecified interim analysis of DEVOTE as part of a Class II Resubmission of...

Teva Announces New Head of Business Development, Strategy and Innovation

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced the appointment of Timothy R. Wright to the Company's executive leadership team, heading business...

Cerulean Appoints Chris Guiffre President & Chief Executive Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting™, today announced that Christopher D. T. Guiffre, J.D., M.B.A., has been appointed...

Panther Biotechnology Announces New Chief Executive Officer

CHICAGO, IL--(Marketwired - March 23, 2015) - Panther Biotechnology, Inc. (OTC PINK: PBYA), a biotechnology company specializing in the development of enhanced therapeutics for the treatment of...

Insmed Appoints Dr. Eugene Sullivan as Chief Medical and Scientific Officer

20 Year Industry Veteran Brings Industry, Clinical and Regulatory Experience in Pulmonary and Orphan Diseases BRIDGEWATER, N.J.--(BUSINESS WIRE)--Insmed Incorporated (NASDAQ:INSM) today announced...

Cortendo AB Announces Appointments of A. Brian Davis as Chief Financial Officer and Stephen Long as Chief Legal Officer

GÖTEBORG, Sweden and RADNOR, Pa.--(BUSINESS WIRE)--Regulatory News: "We are pleased to welcome Brian and Stephen to Cortendo's management team" Cortendo AB (publ) [ticker: CORT on NOTC-A], a...

Aridis Pharmaceuticals Appoints Paul-Andre de Lame, M.D., As Chief Medical Officer

SAN JOSE, Calif., March 23, 2015 /PRNewswire/ -- Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for...

Verde Technologies Announces Jason Sundby As CEO

MINNEAPOLIS, March 23, 2015 /PRNewswire/ -- Verde Technologies, Inc., which develops research-based, scientifically proven solutions to reduce drug abuse, misuse and negative environmental impact,...

Halozyme Therapeutics, Inc. (HALO) Appoints James Mazzola To Lead Corporate Communications, Investor Relations

SAN DIEGO, March 23, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced the appointment of...

Aptose Biosciences Announces Appointment Of Dr. Michael Andreeff To Scientific Advisory Board

SAN DIEGO, CA and TORONTO, March 23, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target...

AcelRx (ACRX) Appoints Howard B. Rosen As Interim CEO

REDWOOD CITY, Calif., March 20, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

StemCells (STEM) Appoints Ian Massey As President And Chief Operating Officer

NEWARK, Calif., March 24, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...

Jay Millerhagen Joins BioSig Technologies as Vice President, Clinical Affairs Veteran Medical Device Executive to Lead Company through Development and Commercialization

LOS ANGELES, CA March 23, 2015 / BioSig Technologies (OTCQB: BSGM), a medical device company developing PURE EP(TM) a proprietary technology platform designed to improve the clinical outcomes of...

Vtesse, Inc. Forms Scientific Advisory Board

GAITHERSBURG, Md., March 25, 2015 /PRNewswire/ -- Vtesse, Inc., a rare disease company focused on developing drugs for Niemann-Pick Disease Type C (NPC) and other severe diseases with great unmet...

PRC Clinical Announces Key Management Appointments And Launches East Coast Operations

San Bruno, CA. March 25, 2015. PRC Clinical, a Silicon-Valley based contract research organization (CRO), announced today several management and executive appointments effective immediately. ­...

BioNano Genomics Appoints Terry Salyer As Chief Commercial Officer

SAN DIEGO, March 26, 2015 /PRNewswire/ -- BioNano Genomics, Inc., the leader in genome mapping, announced today the appointment of Terry Salyeras chief commercial officer. Salyer has more than 20...

Acadia (ACAD) Appoints Daniel Soland To Board Of Directors

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical...